Skip to content

ECLIPSE Study 9: Building resilience and recovery through enhancing cognition and quality

Building Resilience and Recovery through Enhancing Cognition and quality of LIfe in the early PSychosEs (ECLIPSE)­ Study 9: Implementation of Remediation into Early Intervention Services

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN14678860
Enrollment
438
Registered
2016-06-06
Start date
2016-06-06
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-affective psychosis Mental and Behavioural Disorders Schizophrenia, schizotypal and delusional disorders

Interventions

Current Interventions as of 03/04/2019: All participants will be randomised to one of 2 trial arms, to receive either intensive CRT or CRT in a group setting. Both CRT interventions (intensive/group)

Sponsors

King's College London
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Current participant inclusion criteria as of 03/04/2019: 1. Attending an Early Intervention Service or any individual within 5 years of their first episode of psychosis. At least three months from the onset of the first episode of psychosis. 2. Aged between 16 and 45 years 3. Research diagnosis of non-affective psychosis, i.e. schizophrenia, schizo-affective or schizophreniform disorder; 4. Ability to give informed consent. Previous participant inclusion criteria (as of 15/01/2018) 1. Attending an Early Intervention Service for at least three months 2. Aged between 16 and 45 years 3. Research diagnosis of non-­affective psychosis, i.e. schizophrenia, schizo­affective or schizophreniform disorder 4. Ability to give informed consent Previous participant inclusion criteria 1. Attending an Early Intervention Service for at least six months 2. Aged between 16 and 35 years 3. Research diagnosis of non-­affective psychosis, i.e. schizophrenia, schizo­affective or schizophreniform disorder 4. Ability to give informed consent

Exclusion criteria

Exclusion criteria: Current participant exclusion criteria as of 03/04/2019: 1. Inability to communicate in English sufficiently to participate in cognitive testing 2. Underlying organic/neurological condition affecting cognition (e.g. traumatic brain injury, seizure disorder) 3. Co-morbid diagnosis of learning disability 4. A definitive diagnosis of bipolar disorder Previous participant exclusion criteria: 1. Inability to communicate in English sufficiently to participate in cognitive testing 2. Underlying organic/neurological condition affecting cognition(e.g. traumatic brain injury, seizure disorder) 3. Co­-morbid diagnosis of learning disability

Design outcomes

Primary

MeasureTime frame
Achievement of goals is measured using the Goal Attainment Scale at baseline, post-CRT and at 6 months follow up

Secondary

MeasureTime frame
1. Total number of hours of structured activity per week is measured using The Time Use Survey at baseline, post-CRT and at 6 months follow up 2. Costs of health and social care use measured using The Client Service Receipt Inventory at baseline, post-CRT and at 6 months follow up 3. Quality-adjusted life years (QALYs) measured using the EQ-5D at baseline, post-CRT and at 6 months follow up 4. Self-esteem measured using the Rosenberg Self Esteem Scale at baseline, post-CRT and at 6 months follow up

Countries

England, United Kingdom

Contacts

Public ContactEmese Csipke
emese.csipke@kcl.ac.uk+44 (0)20 7848 0762

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 7, 2026